Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-31
2008-12-30
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252040, C514S252020, C514S243000, C514S252030, C514S236500, C544S238000, C544S236000, C544S184000, C544S122000
Reexamination Certificate
active
07470689
ABSTRACT:
Disclosed are compounds of the general formula (I), where the definition of the substituents A, B, D, E, R1and R2are detailed in the description, and the physiologically tolerated salts thereof, a process for the preparation of these compounds and their use as pharmaceuticals.These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin-dependent kinase 2).
REFERENCES:
patent: 7179811 (2007-02-01), Janssens et al.
patent: 7183283 (2007-02-01), Barkoczy et al.
patent: 7189690 (2007-03-01), Rosen et al.
patent: 7196109 (2007-03-01), Lesuisse et al.
patent: 7211577 (2007-05-01), Kyotani et al.
patent: 7229776 (2007-06-01), Holvoet et al.
patent: 7229999 (2007-06-01), Hebeisen et al.
patent: 7232827 (2007-06-01), Lochead et al.
patent: 7232828 (2007-06-01), Pershadsingh et al.
patent: 7232897 (2007-06-01), Hotamisligil et al.
patent: 7232901 (2007-06-01), Mastalerz et al.
patent: 7232904 (2007-06-01), Kato et al.
patent: 7232906 (2007-06-01), Zhang et al.
patent: 7232929 (2007-06-01), Bialer et al.
patent: 7232939 (2007-06-01), Herrmann et al.
patent: 2007/0072866 (2007-03-01), Schoenafinger et al.
patent: 2128464 (1995-01-01), None
patent: 0 639 575 (1995-02-01), None
patent: 1061077 (2000-12-01), None
patent: WO 99/10332 (1999-03-01), None
patent: WO 01/74786 (2001-10-01), None
patent: WO 02/079192 (2002-10-01), None
patent: WO 03/028721 (2003-04-01), None
patent: WO03/035065 (2003-05-01), None
patent: WO 03/059891 (2003-07-01), None
patent: WO 03/066629 (2003-08-01), None
patent: WO 2004/046117 (2004-06-01), None
patent: WO 2004/046130 (2004-06-01), None
patent: WO 2005/085230 (2005-09-01), None
Axel Huwe et al., Small Molecules as Inhibitors of Cyclin-Dependent Kinases, Angew. Chem. Int. Ed. 2003, 42, pp. 2122-2138.
Mong-Hong Lee et al., Regulators of G1 Cyclin-Dependent Kinases and Cancers, Cancer and Metastasis Reviews 22, 2003, pp. 435-449.
Combeau Cecile
Delaisi Christine
Hoelder Swen
Matter Hans
Möller Günter
Aventis Pharma S.A.
Bender Kelly L.
Berch Mark L.
Jaisle Cecilia M
LandOfFree
4-benzimidazol-2-ylpyridazin-3-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-benzimidazol-2-ylpyridazin-3-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-benzimidazol-2-ylpyridazin-3-one derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4036604